Abstract

A real-time calibration to enhance the inter-subject reproducibility of insulin bioavailability measurements was proposed and validated on a diabetic patient with more than 49000 impedance values. The measurement method monitors drug absorption through a transducer consisting of a sensitive material (human abdominal tissue) and an impedance spectrometer. The in-vivo experiments revealed a statistically significant negative second-order polynomial trend in impedance magnitude corresponding to the amount of rapid-acting insulin injected. To manage the uncertainty inherent in the sensing block, the method integrates real-time calibration. Implementing a real-time calibration method based on a customized model identification at each insulin administration resulted in a reduction in deterministic error by a factor of 18. A further reduction in deterministic error for clinical application (46%) was achieved with a customized parameter second-order polynomial model with respect to the customized parameter linear model. Lastly, when less conductive long-acting insulin was administered, an increasing trend in impedance magnitude was observed, aligned with the theoretical framework of the proposed method.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.